Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,692 | -24,690 | -15,160 | -10,373 | -4,689 |
| Depreciation Amortization | 663 | 821 | 580 | 386 | 193 |
| Accounts receivable | -48 | -80 | -2,143 | N/A | N/A |
| Other Working Capital | -217 | 164 | -4,323 | -512 | -1,119 |
| Other Operating Activity | 461 | 2,307 | 3,736 | 1,004 | 374 |
| Operating Cash Flow | $-9,833 | $-21,478 | $-17,310 | $-9,495 | $-5,241 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,425 | -91,657 | N/A | N/A | N/A |
| PPE Investments | -8 | -20 | -13 | -12 | -6 |
| Other Investing Activity | -803 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $2,614 | $-91,677 | $-13 | $-12 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 40 | 75,593 | 75,776 | 35 | 6 |
| Financing Cash Flow | $40 | $75,593 | $75,776 | $35 | $6 |
| Beginning Cash Position | 15,101 | 52,663 | 52,663 | 52,663 | 52,663 |
| End Cash Position | 7,922 | 15,101 | 111,116 | 43,191 | 47,422 |
| Net Cash Flow | $-7,179 | $-37,562 | $58,453 | $-9,472 | $-5,241 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,833 | -21,478 | -17,310 | -9,495 | -5,241 |
| Capital Expenditure | -8 | -20 | -13 | -12 | -6 |
| Free Cash Flow | -9,841 | -21,498 | -17,323 | -9,507 | -5,247 |